StockWatch
·

KANSAI NEROLAC PAINTS LTD. Q2 FY27 Results

KANSAINERQ2 FY27 Results
Filing
Result:Good· Market: Surged#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.3K1.3%21.3%
Total Income2.3K2.2%21.3%
Expenditure2.1K4.1%23.1%
PBT191.9841.1%4.1%
Net Profit148.6438.7%8.5%
OPM9.84%4.77pp1.48pp
NPM6.45%3.84pp0.76pp
EPS1.8438.7%8.9%
View full financials

Revenue grew a healthy 16.1% YoY and adjusted PAT rose 11.5%, but OPM contracted ~118bps (11.0%→9.8%) so profit growth lagged top-line growth, pointing to cost/margin pressure rather than a standout quarter.

KANSAI NEROLAC PAINTS LTD. · QQ2 FY-2027 · THE CALL

Margin miss widens; sequential PAT collapse despite 16% revenue growth

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

12 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade C

Guided 13-14% OPM for FY27; Q2 delivered 9.8%, admitting near-term miss. Sequential PAT collapse unexplained.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Neutral

multi-year

Q2 delivered 16% revenue growth but a devastating 34.9% QoQ PAT collapse and 440-bp OPM miss (9.8% vs. 13-14% guided). Management secured 7-8% pricing retroactively but inflation ran 25%, leaving input-cost headwinds unresolved. Margin recovery deferred to Q4 at earliest. The call exposed execution risk: claimed pricing power did not translate to near-term profitability.

₹2268.8 Cr

Revenue · +16.1% YoY

₹148.6 Cr

Reported PAT · +11.5% YoY

Compressing

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

Standalone Q2 revenue up 18.9%

OVERSTATED

Consolidated delivered Q2 revenue up 16.1% YoY (₹2268.8 Cr)

Operating margins guided at 13-14% for FY27

MISS

Delivered OPM 9.8% in Q2, 440 bps below guidance midpoint

Price increases +7-8% and margin improvement coming in Q3/Q4

MISS

Q2 PAT down 34.9% QoQ despite price hikes; realized NPM only 6.5%

Decorative +3% pricing expected in Q2

MET

Decorative pricing not separately broken out; overall pricing realized 7-8%, not 3%

Industrial pricing +3-5%, so far ~5% booked

Partial

Industrial pricing moves ongoing but overall growth hampered by input cost inflation

Earnings quality

What changed since the last call

Deltas vs. the prior call

OPM target execution risk

Downgrade

Q1 call: 'margin guidance 13-14% maintained.' Q2 delivered 9.8%; management now says 'hopefully by quarter four' — admission of Q2/Q3 miss.

Sequential profitability trajectory

Downgrade

Q1 implied margin expansion; Q2 PAT -34.9% QoQ reveals input-cost and mix headwinds outpaced pricing gains.

Decorative pricing realization

Neutral

Guided +3% in Q2; actual retail/service growth 'mid- to high-single-digit' per call, consistent but pricing impact absorbed by inflation.

Industrial growth confirmation

Upgrade

Strong growth in auto ancillary, construction equipment, infrastructure despite margin pressure. Robust demand acknowledged.

The Q&A

Moderate. Analysts (Aditya Bhartia, Pratik, Aniruddha Joshi) probed margin miss, competitive intensity, and subsidiary drag (Nerofix, Bangladesh). Management defended 13-14% as full-year target, blamed inflation timing, and promised Q4 recovery. On decorative margin contraction vs. industry, management conceded 'tremendous competition intensity.' No aggressive pushback; Q&A was clarifying, not combative.

The exchanges that mattered

Industrial pricing retrospective hikes — Aditya Bhartia, Investec

Answered

Price increases retroactive effective April 1; some from June. Range ~7-8% broadly; crude at ~₹92 ($117). Further discussions ongoing on categories linked to crude.

Gross margin erosion despite pricing — Aditya Bhartia, Investec

Answered

Inflation upwards of 25%; price increase ~7-8%. Remaining gap being discussed further; not all segments realize full pass-through immediately.

13-14% EBITDA margin timeline — Aditya Bhartia, Investec

Partial

By quarter four, think we should be definitely trying to touch that number. Settlements keep happening; difficult to predict exact timing. Clock reset October 1 for next round.

Decorative margin vs. industrial — Aditya Bhartia, Investec

Dodged

Decorative margin contraction lower than industry; our mix focused approach and not participating in low-end products tells the story.

Decorative volume and value growth — Pratik, HSBC

Partial

Volume with current mix correction nearing double-digit value growth. Last three quarters show sequential improvement; pretty good sign.

Competitive intensity in decorative — Pratik, HSBC

Answered

Every quarter hoping it'll go away soon, but not happening. Tremendous competition intensity across regions. No specificity to East India.

Industrial competitive intensity and growth — Aniket, ICICI Securities

Partial

Yes, competition intensity up. Real mix matters; in industrial, real mix drives profitability. Think Q3 should be good as far as growth. Pipeline good in Q3 at least.

Subsidiaries and adhesive business — Aniruddha Joshi, ICICI Securities

Answered

Sri Lanka closed. Nepal doing very well, ~20% growth, healthy profit. Bangladesh problem; trying to recover. Nerofix now part of Kansai; growth double-digit in revenue but serious pricing issue.

Project business pipeline — Aniruddha Joshi, ICICI Securities

Partial

Added ~3,000 dealers; 75-80% machine dealers. Typical 10% network growth annually. Focus on extraction and store growth, not just numerical expansion.

Construction chemical growth — Aniruddha Joshi, ICICI Securities

Answered

Waterproofing growth upward of 30%. Construction chemical 60-70% on small base but growing fast. Penetration across country increasing monthly.

Guidance

Forward guidance and management's confidence

FY27 growth target not formally stated; Q3/Q4 expected to be better

Low

H1 growth +14-14.2% standalone/consolidated; management hopes for sequential improvement but no FY27 number given.

FY27 OPM margin target 13-14% (maintained but near-term misses admitted)

Medium

Q2 delivered 9.8%; management targeting Q4 for recovery. Assumes pricing pass-through, crude stabilization, and cost discipline.

₹601 Cr capex over 2-2.5 years for auto, powder, industrial capacity

Medium

On track per call. No specific quarterly breakdown; capacity ramp timings not quantified.

Risks the call surfaced

Ranked by how much they should concern a holder

Margin compression and input cost inflation

High

Inflation at 25%; pricing realized only 7-8%. QoQ PAT down 34.9% despite price hikes. OPM 9.8% vs. 13-14% guided. Sequentially worsening trend.

Sequential PAT volatility and QoQ collapse

High

Q2 PAT ₹149Cr down 34.9% QoQ despite +16% YoY revenue growth. Indicates mix deterioration, working capital hits, or input-cost spikes not fully disclosed.

Decorative margin contraction and competitive intensity

High

Decorative segment margins lower than industry average due to competitive intensity. Management expects intensity to persist. Mix-heavy strategy (avoiding low-end) limiting volume upside.

Subsidiary and acquisition integration risks

Medium

Nerofix (adhesives) merged mid-FY27, carrying VAM inventory losses (~₹4-5 Cr PAT hit Q2). Bangladesh subsidiary unprofitable and under review. Sri Lanka shut. Growth in adhesives offset by profitability headwinds.

Capex execution and capacity absorption

Medium

₹601 Cr capex over 2-2.5 years for auto, powder, industrial capacity. No specific ramp timeline or capacity absorption assumptions disclosed. Growth expected but not quantified.

Management

Score 6/10. Moderately clear but evasive on margin recovery timeline. MD Pravin Chaudhari acknowledged challenges (inflation, competition, subsidiary drag) but offered 'hopefully Q4' vs. explicit near-term guidance revision. Numbers cited but rationale for misses not fully transparent. Mixed track record. FY27 13-14% margin guidance not on pace (Q2 9.8%). YoY growth solid (+16% revenue, +11% PAT) but QoQ PAT collapse (-34.9%) unexplained in detail. Pricing initiatives underway but lag inflation.

What to watch next
  • 1 · Q3 FY27 (Dec 2026)

    Pricing pass-through from September hikes; OPM recovery target

  • 2 · Q4 FY27 (Mar 2027)

    Management target to reach 13-14% OPM; full-year guidance reconcile

  • 3 · FY28

    Capex completion (auto, powder, industrial capacity); new product revenue ramp

The call exposed execution risk: claimed pricing power did not translate to near-term profitability.

Informational and educational content only. Not investment advice.